148 related articles for article (PubMed ID: 12417112)
1. Novel mutation and multiple mutations found in the human butyrylcholinesterase gene.
Liu W; Cheng J; Iwasaki A; Imanishi H; Hada T
Clin Chim Acta; 2002 Dec; 326(1-2):193-9. PubMed ID: 12417112
[TBL] [Abstract][Full Text] [Related]
2. Human butyrylcholinesterase L330I mutation belongs to a fluoride-resistant gene, by expression in human fetal kidney cells.
Sudo K; Maekawa M; Akizuki S; Magara T; Ogasawara H; Tanaka T
Biochem Biophys Res Commun; 1997 Nov; 240(2):372-5. PubMed ID: 9388484
[TBL] [Abstract][Full Text] [Related]
3. Five new naturally occurring mutations of the BCHE gene and frequencies of 12 butyrylcholinesterase alleles in a Brazilian population.
Mikami LR; Wieseler S; Souza RL; Schopfer LM; Nachon F; Lockridge O; Chautard-Freire-Maia EA
Pharmacogenet Genomics; 2008 Mar; 18(3):213-8. PubMed ID: 18300943
[TBL] [Abstract][Full Text] [Related]
4. Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene.
Primo-Parmo SL; Bartels CF; Wiersema B; van der Spek AF; Innis JW; La Du BN
Am J Hum Genet; 1996 Jan; 58(1):52-64. PubMed ID: 8554068
[TBL] [Abstract][Full Text] [Related]
5. Novel mutations in the BCHE gene in patients with no butyrylcholinesterase activity.
On-Kei Chan A; Lam CW; Tong SF; Man Tung C; Yung K; Chan YW; Au KM; Yuen YP; Hung CT; Ng KP; Shek CC
Clin Chim Acta; 2005 Jan; 351(1-2):155-9. PubMed ID: 15563885
[TBL] [Abstract][Full Text] [Related]
6. Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity.
Duysen EG; Bartels CF; Lockridge O
J Pharmacol Exp Ther; 2002 Aug; 302(2):751-8. PubMed ID: 12130740
[TBL] [Abstract][Full Text] [Related]
7. Butyrylcholinesterase genes in individuals with abnormal inhibition numbers and with trace activity: one common mutation and two novel silent genes.
Dey DC; Maekawa M; Sudo K; Kanno T
Ann Clin Biochem; 1998 Mar; 35 ( Pt 2)():302-10. PubMed ID: 9547905
[TBL] [Abstract][Full Text] [Related]
8. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
Gätke MR; Bundgaard JR; Viby-Mogensen J
Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
[TBL] [Abstract][Full Text] [Related]
9. Frequency of butyrylcholinesterase gene mutations in individuals with abnormal inhibition numbers: an Italian-population study.
Lando G; Mosca A; Bonora R; Azzario F; Penco S; Marocchi A; Panteghini M; Patrosso MC
Pharmacogenetics; 2003 May; 13(5):265-70. PubMed ID: 12724618
[TBL] [Abstract][Full Text] [Related]
10. The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology.
Podoly E; Shalev DE; Shenhar-Tsarfaty S; Bennett ER; Ben Assayag E; Wilgus H; Livnah O; Soreq H
J Biol Chem; 2009 Jun; 284(25):17170-17179. PubMed ID: 19383604
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in the BCHE gene and phenotype identified in a child with low butyrylcholinesterase activity: a case report.
Yu R; Guo Y; Dan Y; Tan W; Mao Q; Deng G
BMC Med Genet; 2018 Apr; 19(1):58. PubMed ID: 29631548
[TBL] [Abstract][Full Text] [Related]
12. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population.
Yen T; Nightingale BN; Burns JC; Sullivan DR; Stewart PM
Clin Chem; 2003 Aug; 49(8):1297-308. PubMed ID: 12881446
[TBL] [Abstract][Full Text] [Related]
13. Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene.
Wichmann S; Færk G; Bundgaard JR; Gätke MR
Pharmacogenet Genomics; 2016 Jul; 26(7):351-6. PubMed ID: 27031121
[TBL] [Abstract][Full Text] [Related]
14. DNA mutations associated with the human butyrylcholinesterase J-variant.
Bartels CF; James K; La Du BN
Am J Hum Genet; 1992 May; 50(5):1104-14. PubMed ID: 1349196
[TBL] [Abstract][Full Text] [Related]
15. Concordance of butyrylcholinesterase phenotype with genotype: implications for biochemical reporting.
Parnas ML; Procter M; Schwarz MA; Mao R; Grenache DG
Am J Clin Pathol; 2011 Feb; 135(2):271-6. PubMed ID: 21228368
[TBL] [Abstract][Full Text] [Related]
16. Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India.
Manoharan I; Wieseler S; Layer PG; Lockridge O; Boopathy R
Pharmacogenet Genomics; 2006 Jul; 16(7):461-8. PubMed ID: 16788378
[TBL] [Abstract][Full Text] [Related]
17. Expression of three naturally occurring genetic variants (G75R, E90D, I99M) of the BCHE gene of human butyrylcholinesterase.
Mikami LR; Wieseler S; Souza RL; Schopfer LM; Lockridge O; Chautard-Freire-Maia EA
Pharmacogenet Genomics; 2007 Sep; 17(9):681-5. PubMed ID: 17700357
[TBL] [Abstract][Full Text] [Related]
18. The butyrylcholinesterase K-variant shows similar cellular protein turnover and quaternary interaction to the wild-type enzyme.
Altamirano CV; Bartels CF; Lockridge O
J Neurochem; 2000 Feb; 74(2):869-77. PubMed ID: 10646540
[TBL] [Abstract][Full Text] [Related]
19. Characterization of four BCHE mutations associated with prolonged effect of suxamethonium.
Brazzolotto X; Courcelle S; Sauvanet C; Guillon V; Igert A; Kononchik J; Nachon F; Ceppa F; Delacour H
Pharmacogenomics J; 2021 Apr; 21(2):165-173. PubMed ID: 33024248
[TBL] [Abstract][Full Text] [Related]
20. Production of the butyrylcholinesterase knockout mouse.
Li B; Duysen EG; Saunders TL; Lockridge O
J Mol Neurosci; 2006; 30(1-2):193-5. PubMed ID: 17192674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
